The third complement component (C3) is an acute phase protein that plays a central role in reperfusion injury in several organ models. To investigate the contribution of local synthesis of C3 and distinguish it from that of circulating complement mainly produced by hepatic synthesis, we employed a mouse renal isograft model. Our model demonstrated a close relationship between the extent of intr...

Activation of the alternative pathway of complement commences with the formation of an initial fluid-phase C3 convertase. Treatment of C3 with the nucleophilic reagent methylamine has previously been shown to result in the cleavage of an intramolecular thioester bond and to induce C3b-like properties, including the ability to form a fluid-phase C3 convertase. This report examines the hypothesis...

Previous studies from this laboratory have demonstrated that Mycobacterium leprae, an obligate intracellular bacterial parasite, enters human mononuclear phagocytes via complement receptors on these host cells and bacterium-bound C3. The present study investigates the role of M. leprae surface molecules in C3 fixation and phagocytosis. By enzyme-linked immunosorbent assay, C3 binds selectively ...

We have recently reported the isolation from rabbit alveolar macrophages of a receptor which retained its ligand-binding activity for the third component of complement (C3) and for its major proteolytic derived activation fragment (C3b). The isolated receptor demonstrated a greater ability to bind C3b than an equimolar amount of C3. C3b differs from C3 in at least two ways: it is a proteolytic ...

Plasma concentrations of the third complement component (C3) predict the risk of myocardial infarction. Because chylomicrons stimulate C3 production by adipocytes in vitro, we investigated plasma C3 changes in vivo after an oral fat load. Thirty-seven subjects (20 normolipidemic patients with coronary artery disease [CAD] and 17 healthy control subjects) underwent an oral fat load (50 g/m(2)). ...

The Clostridium botulinum C3 exoenzyme selectively ADP-ribosylates low molecular weight GTP-binding proteins RhoA, B and C. This covalent modification inhibits Rho signaling activity, resulting in distinct actin cytoskeleton changes. Although C3 exoenzyme has no binding, the translocation domain assures that C3 enters cells and acts intracellularly. C3 uptake is thought to occur due to the high...

Platelet-associated C3 (PA-C3) was measured with a quantitative immunofluorescence assay. With this assay, PA-C3 levels were determined for 78 normal volunteers, 30 patients with immune thrombocytopenic purpura (ITP), and 20 patients with nonimmune thrombocytopenias. Platelet-associated IgG (PA-IgG) levels were also measured with our standard quantitative immunofluorescence assay. All patients ...

BACKGROUND C3 glomerulonephritis (C3 GN) is a recently defined entity characterized by predominant C3 deposition in glomeruli due to abnormal activation of the alternative pathway of complement system. C3 GN has been reported to be associated with several systemic diseases. However, the association between C3 GN and multiple myeloma (MM) has not been well established. METHODS We herein descri...

k=0 (−1)n−k ck(T ) λk . Then, as well known, c0(T ) = 0 and c1(T ) = n . If T differs from the star (Sn) and the path (Pn), which requires n ≥ 5 , then c2(Sn) < c2(T ) < c2(Pn) and c3(Sn) < c3(T ) < c3(Pn) . If n = 4 , then c3(Sn) = c3(Pn) . AMS Mathematics Subject Classification (2000): 05C05, 05C12, 05C50

background: beta-thalassemia major is one of the major health problems in our country. many studies have confirmed the fact that, these patients have an increased susceptibility to bacterial infections. objective: in this study, we have assessed the humoral immune system in 68 thalassemic patients by measuring their serum concentration of immunoglobulin g (igg), igm, iga, c3 and c4 in order to ...